On January 29, Jiangsu Hengrui Pharmaceuticals (01276) spent 21.074 million yuan to repurchase 371,600 shares of A shares.
Hengrui Medicine (01276) announced that on January 29, 2026, the company will spend 210.74 million yuan to repurchase 371,600 shares of A shares.
Jiangsu Hengrui Pharmaceuticals (01276) announced that on January 29, 2026, the company will spend 2107.4 million RMB to repurchase 371,600 A shares.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
